Your browser doesn't support javascript.
loading
Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14.
Hertzberg, Mark; Gandhi, Maher K; Trotman, Judith; Butcher, Belinda; Taper, John; Johnston, Amanda; Gill, Devinder; Ho, Shir-Jing; Cull, Gavin; Fay, Keith; Chong, Geoff; Grigg, Andrew; Lewis, Ian D; Milliken, Sam; Renwick, William; Hahn, Uwe; Filshie, Robin; Kannourakis, George; Watson, Anne-Marie; Warburton, Pauline; Wirth, Andrew; Seymour, John F; Hofman, Michael S; Hicks, Rodney J.
Affiliation
  • Hertzberg M; Department of Haematology, Prince of Wales Hospital and University of NSW, Randwick, NSW, Australia mhertzberg10@gmail.com.
  • Gandhi MK; The University of Queensland Diamantina Institute Woolloongabba, Brisbane, QLD, Australia.
  • Trotman J; Department of Haematology, Princess Alexandra Hospital Brisbane, QLD, Australia.
  • Butcher B; Department of Haematology, Repatriation General Hospital Concord and University of Sydney, NSW, Australia.
  • Taper J; WriteSource Medical Pty Ltd., Lane Cove, NSW, Australia.
  • Johnston A; Nepean Cancer Care Centre, Nepean Hospital Nepean, NSW, Australia.
  • Gill D; Department of Haematology, Westmead Hospital, NSW, Australia.
  • Ho SJ; Department of Haematology, Princess Alexandra Hospital Brisbane, QLD, Australia.
  • Cull G; Department of Haematology, St George Hospital Kogarah, NSW, Australia.
  • Fay K; Department of Haematology, Sir Charles Gairdner Hospital Perth, WA, Australia.
  • Chong G; Department of Haematology, Royal North Shore Hospital, St Leonard's, NSW, Australia.
  • Grigg A; Olivia Newton John Cancer & Wellness Centre, Austin Hospital, Heidelberg, VIC, Australia.
  • Lewis ID; Department of Haematology, Austin Hospital, Heidelberg, VIC, Australia.
  • Milliken S; Department of Haematology, Royal Adelaide Hospital Adelaide, SA, Australia.
  • Renwick W; Department of Haematology, St Vincent's Hospital Darlinghurst, NSW, Australia.
  • Hahn U; Department of Haematology, Royal Melbourne Hospital Parkville, VIC, Australia.
  • Filshie R; Department of Haematology, The Queen Elizabeth Hospital, SA, Australia.
  • Kannourakis G; Department of Haematology, St Vincent's Hospital Melbourne, VIC, Australia.
  • Watson AM; Ballarat Oncology and Haematology Service and Fiona Elsey Cancer Research Institute, Ballarat, VIC, Australia.
  • Warburton P; Department of Haematology, Liverpool Hospital, Liverpool, NSW, Australia.
  • Wirth A; Department of Haematology, Wollongong Hospital, Wollongong, NSW, Australia.
  • Seymour JF; Department of Radiation Oncology, Peter MacCallum Cancer Centre East Melbourne, VIC, Australia.
  • Hofman MS; Department of Haematology, Peter MacCallum Cancer Centre East Melbourne and University of Melbourne, Parkville, VIC, Australia.
  • Hicks RJ; Department of Cancer Imaging, Peter MacCallum Cancer Centre East Melbourne, VIC, Australia.
Haematologica ; 102(2): 356-363, 2017 02.
Article in En | MEDLINE | ID: mdl-28143954

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Positron-Emission Tomography Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2017 Type: Article Affiliation country: Australia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Positron-Emission Tomography Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2017 Type: Article Affiliation country: Australia